Rizatriptan versus Betahistin in Vestibular Migraine treatment

Phase 3

• Conditions: Condition 1: vestibular migraine. Condition 2: vestibular migraine.; Migraine; Other disorders of vestibular function; H81.8X

• Registration Number: IRCT20230913059428N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Including the International Headache Society criteria for vestibular migraine
Acute vertigo with moderate to severe intensity

Exclusion Criteria

Patients with suspected vestibular disorders other than vestibular migraine
Patients with a suspected history of Orthostatic Hypotension or panic disorders
history of basilar or hemiplegic migraine
Presence of severe kidney or liver disorders
Symptoms suggestive of ischemic heart disease
history of HTN
history of previous TIA/stoke
history of drug or substance or alcohol abuse
Systolic blood pressure above 160 or diastolic blood pressure above 90
pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dizziness intensity. Timepoint: At the beginning of the study (before the start of the intervention) and 4 and 24 hours after taking the drug. Method of measurement: Compiled questionnaire.